BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 24352521)

  • 1. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
    Zoppini G; Negri C; Stoico V; Casati S; Pichiri I; Bonora E
    Metabolism; 2012 Jan; 61(1):22-9. PubMed ID: 21676418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy.
    Popescu T; Moţa M
    Rom J Intern Med; 2009; 47(3):235-41. PubMed ID: 20446438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.
    Rema M; Srivastava BK; Anitha B; Deepa R; Mohan V
    Diabet Med; 2006 Sep; 23(9):1029-36. PubMed ID: 16922712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and epidemiological aspects of diabetic retinopathy and its relationship with diabetic nephropathy].
    Evgrafov VIu; Mamaeva GG; Bishele NA; Liudina LI
    Vestn Oftalmol; 1996; 112(1):40-3. PubMed ID: 8659071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
    Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
    Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.
    Mäkinen VP; Soininen P; Kangas AJ; Forsblom C; Tolonen N; Thorn LM; Viikari J; Raitakari OT; Savolainen M; Groop PH; Ala-Korpela M;
    J Intern Med; 2013 Apr; 273(4):383-95. PubMed ID: 23279644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
    Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
    Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of measuring non-HDL cholesterol in type 2 diabetes patients.
    Ram N; Ahmed B; Hashmi F; Jabbar A
    J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects.
    Lee IT; Wang CY; Huang CN; Fu CC; Sheu WH
    J Diabetes Complications; 2013; 27(3):243-7. PubMed ID: 23276621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).
    Raman R; Gupta A; Krishna S; Kulothungan V; Sharma T
    J Diabetes Complications; 2012; 26(2):123-8. PubMed ID: 22446033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study.
    Tolonen N; Hietala K; Forsblom C; Harjutsalo V; Mäkinen VP; Kytö J; Summanen PA; Thorn LM; Wadén J; Gordin D; Taskinen MR; Groop PH;
    J Intern Med; 2013 Nov; 274(5):469-79. PubMed ID: 23844944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of diabetic retinopathy in type 2 diabetic patients.
    Cai XL; Wang F; Ji LN
    Chin Med J (Engl); 2006 May; 119(10):822-6. PubMed ID: 16732984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.